...
首页> 外文期刊>Plastic and reconstructive surgery >Bacteriophage therapy for staphylococcus aureus biofilm-infected wounds: A new approach to chronic wound care
【24h】

Bacteriophage therapy for staphylococcus aureus biofilm-infected wounds: A new approach to chronic wound care

机译:噬菌体治疗金黄色葡萄球菌生物膜感染的伤口:慢性伤口护理的新方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Bacterial biofilms, which are critical mediators of chronic wounds, remain difficult to treat with traditional methods. Bacteriophage therapy against biofilm has not been rigorously studied in vivo. The authors evaluate the efficacy of a species-specific bacteriophage against Staphylococcus aureus biofilm-infected wounds using a validated, quantitative, rabbit ear model. METHODS: Six-millimeter dermal punch wounds in New Zealand rabbit ears were inoculated with wild-type or mutant, biofilm-deficient S. aureus. In vivo biofilm was established and maintained using procedures from our previously published wound biofilm model. Wounds were left untreated, or treated every other day with topical S. aureus-specific bacteriophage, sharp débridement, or both. Histologic wound healing and viable bacterial count measurements, and scanning electron microscopy were performed following harvest. RESULTS: Wild-type S. aureus biofilm wounds demonstrated no differences in healing or viable bacteria following bacteriophage application or sharp débridement alone. However, the combination of both treatments significantly improved all measured wound healing parameters (p < 0.05) and reduced bacteria counts (p = 0.03), which was confirmed by scanning electron microscopy. Bacteriophage treatment of biofilm-deficient S. aureus mutant wounds alone also resulted in similar trends for both endpoints (p < 0.05). CONCLUSIONS: Bacteriophages can be an effective topical therapy against S. aureus biofilm-infected wounds in the setting of a deficient (mutant) or disrupted (débridement) biofilm structure. Combination treatment aimed at disturbing the extracellular biofilm matrix, allowing for increased penetration of species-specific bacteriophages, represents a new and potentially effective approach to chronic wound care. These results establish principles for biofilm therapy that may be applied to several different clinical and surgical problems.
机译:背景:细菌生物膜是慢性伤口的重要介质,但传统方法仍然难以治疗。尚未对体内针对生物膜的噬菌体疗法进行严格研究。作者使用一种经过验证的定量兔耳模型评估了一种物种特异性噬菌体对金黄色葡萄球菌生物膜感染伤口的功效。方法:在新西兰兔耳的六毫米皮肤打孔伤口上接种野生型或突变型生物膜缺陷型金黄色葡萄球菌。使用我们先前公布的伤口生物膜模型中的程序建立并维持体内生物膜。伤口不予治疗,或隔天用局部金黄色葡萄球菌特异性噬菌体,锋利的清创术或两者兼治。收获后进行组织学伤口愈合和可行细菌计数测量,以及扫描电子显微镜检查。结果:野生型金黄色葡萄球菌生物膜伤口在应用噬菌体或仅进行清晰的清创术后,在愈合或存活细菌方面无差异。然而,两种治疗方法的结合显着改善了所有测得的伤口愈合参数(p <0.05)并减少了细菌数量(p = 0.03),这已通过扫描电子显微镜得到了证实。噬菌体治疗仅生物膜缺陷的金黄色葡萄球菌突变体伤口也导致两个终点的趋势相似(p <0.05)。结论:噬菌体可以在缺乏(突变)或破坏(清创)生物膜结构的情况下对金黄色葡萄球菌生物膜感染的伤口进行有效的局部治疗。旨在扰乱细胞外生物膜基质,允许增加物种特异性噬菌体渗透的联合治疗,代表了一种新型且潜在有效的慢性伤口护理方法。这些结果建立了生物膜治疗的原理,可以应用于几种不同的临床和手术问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号